United World Antiviral Research Network (UWARN)
Funded at University of Washington · NIH-11613750 · Data updated 2026-11-12
A year-long, globally connected effort to study emerging viruses and how they spread, with a focus on improving detection and understanding of infections in people living with HIV and in communities in LMICs.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | May 22, 2020 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $135,000 |
| NIH project number | 3U01AI151698-06S2 |
| Project ID | NIH-11613750 on NIH RePORTER |
Who could benefit from this research
✓Could help
People in LMICs and regions affected by arboviruses and coronaviruses who may benefit from improved surveillance and public health responses.
✕Less likely to help
Individuals not directly involved in surveillance activities or not in study regions may experience no direct benefit.
What this research studies
UWARN brings together researchers at the University of Washington with partners in Brazil, Senegal, Taiwan, and soon Thailand to study arboviruses and coronaviruses using a One Health approach. The project analyzes how viruses evolve in humans and animal hosts, tracks variants, and explores environmental factors that influence spread. Findings aim to inform global health responses, surge testing, and targeted interventions in high-burden regions. This research may lead to better diagnostics, surveillance, and prevention strategies for communities at risk.
Why it matters
Potential benefit: If successful, the project could improve how we detect, monitor, and respond to emerging viruses, potentially protecting vulnerable populations including people living with HIV.
How similar studies have gone: Past work has shown that coordinated, One Health approaches can enhance understanding of virus evolution and outbreak dynamics, with positive implications for public health.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Rabinowitz, Peter Macgarr — University of Washington
- Study coordinator: Rabinowitz, Peter Macgarr
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.